#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Stacy Roughan Email
VP, Corporate Communications & IR . Cortexyme
How to contact Stacy Roughan
Join and see Stacy's contact info for free!Current Roles
Employees:
19Revenue:
$10.2MAbout
Cortexyme is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimerￃﾢ￢ﾂﾬ￢ﾄﾢs and other degenerative diseases. Cortexyme is targeting a specific pathogen found in the brain of Alzheimerￃﾢ￢ﾂﾬ￢ﾄﾢs patients that causes neurodegeneration and other pathology in animal models. Cortexymeￃﾢ￢ﾂﾬ￢ﾄﾢs lead small molecule, atuzaginstat (COR388), has advanced through Phase Ib and is currently the subject of a Phase 2/3 GAIN clinical trial in mild to moderate Alzheimerￃﾢ￢ﾂﾬ￢ﾄﾢs disease patients.Cortexyme Address
269 East Grand AvenueSan Francisco, CA
United States